

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * cAMP catabolic process (GO:0006198) | 5.70350973 |
| 2 | * cyclic nucleotide catabolic process (GO:0009214) | 5.10362739 |
| 3 | protein prenylation (GO:0018342) | 4.83884114 |
| 4 | prenylation (GO:0097354) | 4.83884114 |
| 5 | monoubiquitinated protein deubiquitination (GO:0035520) | 4.58178828 |
| 6 | postsynaptic membrane organization (GO:0001941) | 4.48629054 |
| 7 | neuron cell-cell adhesion (GO:0007158) | 4.42447545 |
| 8 | interkinetic nuclear migration (GO:0022027) | 4.42443934 |
| 9 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.37413240 |
| 10 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.31539587 |
| 11 | negative regulation of complement activation (GO:0045916) | 4.26746872 |
| 12 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.22199275 |
| 13 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.21741871 |
| 14 | vocalization behavior (GO:0071625) | 4.17506404 |
| 15 | presynaptic membrane assembly (GO:0097105) | 4.14922469 |
| 16 | positive regulation of vascular permeability (GO:0043117) | 4.08291387 |
| 17 | response to dexamethasone (GO:0071548) | 4.01104121 |
| 18 | neuronal action potential propagation (GO:0019227) | 3.98832186 |
| 19 | pericardium development (GO:0060039) | 3.89741550 |
| 20 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.86990050 |
| 21 | midgut development (GO:0007494) | 3.82542011 |
| 22 | citrulline biosynthetic process (GO:0019240) | 3.81787090 |
| 23 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.81674977 |
| 24 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.80083800 |
| 25 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.79087279 |
| 26 | synaptic vesicle exocytosis (GO:0016079) | 3.74416758 |
| 27 | nucleus localization (GO:0051647) | 3.72904549 |
| 28 | negative regulation of protein activation cascade (GO:2000258) | 3.70975442 |
| 29 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.69088647 |
| 30 | Rap protein signal transduction (GO:0032486) | 3.67349923 |
| 31 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.58934849 |
| 32 | * regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.57059021 |
| 33 | regulation of synaptic vesicle transport (GO:1902803) | 3.56885481 |
| 34 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.54094990 |
| 35 | regulation of energy homeostasis (GO:2000505) | 3.52318357 |
| 36 | skeletal muscle contraction (GO:0003009) | 3.51230023 |
| 37 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.47998317 |
| 38 | glutamate secretion (GO:0014047) | 3.47419859 |
| 39 | muscle filament sliding (GO:0030049) | 3.46278485 |
| 40 | actin-myosin filament sliding (GO:0033275) | 3.46278485 |
| 41 | nuclear pore complex assembly (GO:0051292) | 3.45246623 |
| 42 | hepatocyte differentiation (GO:0070365) | 3.44789132 |
| 43 | negative regulation of vascular permeability (GO:0043116) | 3.44473776 |
| 44 | glycogen catabolic process (GO:0005980) | 3.42951549 |
| 45 | * regulation of cell communication by electrical coupling (GO:0010649) | 3.42642044 |
| 46 | presynaptic membrane organization (GO:0097090) | 3.41364627 |
| 47 | regulation of skeletal muscle contraction (GO:0014819) | 3.41209789 |
| 48 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.40332286 |
| 49 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.39827203 |
| 50 | response to growth hormone (GO:0060416) | 3.38104707 |
| 51 | protein localization to synapse (GO:0035418) | 3.37931677 |
| 52 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.36563468 |
| 53 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 3.32852277 |
| 54 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.32528955 |
| 55 | synaptic vesicle endocytosis (GO:0048488) | 3.29516020 |
| 56 | protein K11-linked deubiquitination (GO:0035871) | 3.20542582 |
| 57 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.19473132 |
| 58 | glucan catabolic process (GO:0009251) | 3.19431305 |
| 59 | cGMP-mediated signaling (GO:0019934) | 3.17905474 |
| 60 | actin filament-based movement (GO:0030048) | 3.17173299 |
| 61 | inositol phosphate catabolic process (GO:0071545) | 3.15585127 |
| 62 | regulation of centriole replication (GO:0046599) | 3.15228612 |
| 63 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.15120871 |
| 64 | positive regulation of odontogenesis (GO:0042482) | 3.13803564 |
| 65 | mechanosensory behavior (GO:0007638) | 3.12929788 |
| 66 | negative regulation of humoral immune response (GO:0002921) | 3.10507097 |
| 67 | membrane depolarization during action potential (GO:0086010) | 3.07814654 |
| 68 | homocysteine metabolic process (GO:0050667) | 3.07384064 |
| 69 | synaptic transmission, glutamatergic (GO:0035249) | 3.06856055 |
| 70 | fibroblast migration (GO:0010761) | 3.03850613 |
| 71 | negative regulation of dendrite development (GO:2000171) | 3.02301880 |
| 72 | negative regulation of B cell mediated immunity (GO:0002713) | 3.00867975 |
| 73 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.00867975 |
| 74 | cellular polysaccharide catabolic process (GO:0044247) | 2.98973151 |
| 75 | positive regulation of phosphatase activity (GO:0010922) | 2.98611953 |
| 76 | actomyosin structure organization (GO:0031032) | 2.95518929 |
| 77 | protein K48-linked deubiquitination (GO:0071108) | 2.95198118 |
| 78 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.93930837 |
| 79 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.93838749 |
| 80 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.92036274 |
| 81 | neuron-neuron synaptic transmission (GO:0007270) | 2.91914083 |
| 82 | * regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.91580020 |
| 83 | startle response (GO:0001964) | 2.90852007 |
| 84 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.89696741 |
| 85 | neuromuscular synaptic transmission (GO:0007274) | 2.87552598 |
| 86 | regulation of synapse structural plasticity (GO:0051823) | 2.87204949 |
| 87 | striated muscle contraction (GO:0006941) | 2.87076442 |
| 88 | carnitine shuttle (GO:0006853) | 2.85951777 |
| 89 | locomotory exploration behavior (GO:0035641) | 2.85222155 |
| 90 | * regulation of relaxation of muscle (GO:1901077) | 2.84924670 |
| 91 | regulation of coenzyme metabolic process (GO:0051196) | 2.82485500 |
| 92 | regulation of cofactor metabolic process (GO:0051193) | 2.82485500 |
| 93 | actin-mediated cell contraction (GO:0070252) | 2.82242981 |
| 94 | axonal fasciculation (GO:0007413) | 2.81705081 |
| 95 | NADH metabolic process (GO:0006734) | 2.80373360 |
| 96 | cardiac myofibril assembly (GO:0055003) | 2.79453962 |
| 97 | cardiac muscle hypertrophy (GO:0003300) | 2.79322810 |
| 98 | proline transport (GO:0015824) | 2.75043646 |
| 99 | * regulation of actin filament-based movement (GO:1903115) | 2.74952520 |
| 100 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.74553214 |
| 101 | iron ion import (GO:0097286) | 2.74364166 |
| 102 | nuclear pore organization (GO:0006999) | 2.74201719 |
| 103 | neutrophil mediated immunity (GO:0002446) | 2.73841013 |
| 104 | striated muscle hypertrophy (GO:0014897) | 2.73563747 |
| 105 | oxygen transport (GO:0015671) | 2.72915945 |
| 106 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.72276467 |
| 107 | myeloid leukocyte mediated immunity (GO:0002444) | 2.72068191 |
| 108 | neurotransmitter secretion (GO:0007269) | 2.71646617 |
| 109 | protein K63-linked deubiquitination (GO:0070536) | 2.71526821 |
| 110 | long-term synaptic potentiation (GO:0060291) | 2.70659628 |
| 111 | genitalia morphogenesis (GO:0035112) | 2.68460754 |
| 112 | response to inactivity (GO:0014854) | 2.66404938 |
| 113 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.66306286 |
| 114 | striated muscle atrophy (GO:0014891) | 2.65900231 |
| 115 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.65260694 |
| 116 | carnitine transmembrane transport (GO:1902603) | 2.64687082 |
| 117 | myotube cell development (GO:0014904) | 2.64535376 |
| 118 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.64234617 |
| 119 | morphogenesis of an epithelial sheet (GO:0002011) | 2.63158245 |
| 120 | negative regulation of TOR signaling (GO:0032007) | 2.62405584 |
| 121 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.62244393 |
| 122 | regulation of p38MAPK cascade (GO:1900744) | 2.62145989 |
| 123 | skeletal muscle adaptation (GO:0043501) | 2.61408451 |
| 124 | polysaccharide catabolic process (GO:0000272) | 2.61368420 |
| 125 | regulation of respiratory system process (GO:0044065) | 2.61259435 |
| 126 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.58992304 |
| 127 | positive regulation of cation channel activity (GO:2001259) | 2.58514332 |
| 128 | cellular response to ethanol (GO:0071361) | 2.58474052 |
| 129 | negative regulation of hormone metabolic process (GO:0032351) | 2.58294405 |
| 130 | interferon-gamma production (GO:0032609) | 2.58247004 |
| 131 | citrulline metabolic process (GO:0000052) | 2.58148798 |
| 132 | cerebellar granule cell differentiation (GO:0021707) | 2.56384269 |
| 133 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.55866354 |
| 134 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.55367487 |
| 135 | neuron recognition (GO:0008038) | 2.54872149 |
| 136 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.54662285 |
| 137 | dorsal/ventral axis specification (GO:0009950) | 2.54473173 |
| 138 | establishment of protein localization to Golgi (GO:0072600) | 2.54104319 |
| 139 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.53214049 |
| 140 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.52439453 |
| 141 | positive regulation of synapse assembly (GO:0051965) | 2.51887814 |
| 142 | positive regulation of myoblast differentiation (GO:0045663) | 2.51318534 |
| 143 | positive regulation of astrocyte differentiation (GO:0048711) | 2.50885961 |
| 144 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.50060405 |
| 145 | striated muscle adaptation (GO:0014888) | 2.49954896 |
| 146 | pore complex assembly (GO:0046931) | 2.48566041 |
| 147 | tricarboxylic acid cycle (GO:0006099) | 2.48488443 |
| 148 | myofibril assembly (GO:0030239) | 2.48437946 |
| 149 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.48228915 |
| 150 | * cAMP metabolic process (GO:0046058) | 2.48091779 |
| 151 | * regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.48075077 |
| 152 | * regulation of calcium ion transmembrane transport (GO:1903169) | 2.48075077 |
| 153 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.47924471 |
| 154 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.47776293 |
| 155 | muscle cell cellular homeostasis (GO:0046716) | 2.47710714 |
| 156 | fatty acid transmembrane transport (GO:1902001) | 2.47196250 |
| 157 | membrane depolarization (GO:0051899) | 2.46024140 |
| 158 | inositol phosphate dephosphorylation (GO:0046855) | 2.45949396 |
| 159 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.45949396 |
| 160 | regulation of neurotransmitter secretion (GO:0046928) | 2.45612353 |
| 161 | urea cycle (GO:0000050) | 2.45277460 |
| 162 | * regulation of striated muscle contraction (GO:0006942) | 2.44968866 |
| 163 | sarcomere organization (GO:0045214) | 2.44542657 |
| 164 | regulation of synapse assembly (GO:0051963) | 2.44250506 |
| 165 | glutamate receptor signaling pathway (GO:0007215) | 2.41318852 |
| 166 | innervation (GO:0060384) | 2.40556239 |
| 167 | regulation of postsynaptic membrane potential (GO:0060078) | 2.39110303 |
| 168 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.39031777 |
| 169 | positive regulation of neurotransmitter transport (GO:0051590) | 2.38973937 |
| 170 | opioid receptor signaling pathway (GO:0038003) | 2.38509472 |
| 171 | detection of calcium ion (GO:0005513) | 2.38316513 |
| 172 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.36980741 |
| 173 | positive T cell selection (GO:0043368) | 2.36329066 |
| 174 | response to interleukin-15 (GO:0070672) | 2.36250464 |
| 175 | regulation of sarcomere organization (GO:0060297) | 2.35199883 |
| 176 | positive regulation of membrane potential (GO:0045838) | 2.34978058 |
| 177 | cardiac muscle contraction (GO:0060048) | 2.34860438 |
| 178 | behavioral response to pain (GO:0048266) | 2.33472435 |
| 179 | tolerance induction (GO:0002507) | 2.33468319 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.95428297 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.49100236 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.85775418 |
| 4 | * BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.36500548 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.01132725 |
| 6 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.88875125 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.71276017 |
| 8 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.62406399 |
| 9 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.43635030 |
| 10 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.42889998 |
| 11 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.39152709 |
| 12 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.35354547 |
| 13 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.27014138 |
| 14 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.24933670 |
| 15 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.22837806 |
| 16 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.19279961 |
| 17 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.18319690 |
| 18 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.16359439 |
| 19 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.12892976 |
| 20 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.11412630 |
| 21 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.10439845 |
| 22 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.10235572 |
| 23 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.02760291 |
| 24 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.02660025 |
| 25 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.93667228 |
| 26 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.93046035 |
| 27 | P300_19829295_ChIP-Seq_ESCs_Human | 1.92394284 |
| 28 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.89746116 |
| 29 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.88275421 |
| 30 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.84870304 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.84765170 |
| 32 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.82381216 |
| 33 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.80873936 |
| 34 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.74228771 |
| 35 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.73127180 |
| 36 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.73127180 |
| 37 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.68036390 |
| 38 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.68030267 |
| 39 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.68015660 |
| 40 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.67981260 |
| 41 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.67180583 |
| 42 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.64935666 |
| 43 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.63788811 |
| 44 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.59977637 |
| 45 | FUS_26573619_Chip-Seq_HEK293_Human | 1.59105420 |
| 46 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.58356589 |
| 47 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.58356589 |
| 48 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.57935104 |
| 49 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.55674524 |
| 50 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.54431056 |
| 51 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.53484720 |
| 52 | AR_25329375_ChIP-Seq_VCAP_Human | 1.52678337 |
| 53 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.51530900 |
| 54 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.51269706 |
| 55 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.50689481 |
| 56 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.50272026 |
| 57 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.47262986 |
| 58 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.45828699 |
| 59 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.45319960 |
| 60 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.45286009 |
| 61 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.43787703 |
| 62 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.42422363 |
| 63 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.41283072 |
| 64 | * STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.41209627 |
| 65 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.41080269 |
| 66 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.40527263 |
| 67 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.40347783 |
| 68 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.39286753 |
| 69 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.38440345 |
| 70 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.37658022 |
| 71 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.37294905 |
| 72 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.36166218 |
| 73 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.35887680 |
| 74 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.34222989 |
| 75 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.33434184 |
| 76 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.32113512 |
| 77 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.31612218 |
| 78 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.31069240 |
| 79 | EWS_26573619_Chip-Seq_HEK293_Human | 1.30558999 |
| 80 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.30339091 |
| 81 | CJUN_26792858_Chip-Seq_BT549_Human | 1.29951489 |
| 82 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.29237393 |
| 83 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28340139 |
| 84 | GATA1_22025678_ChIP-Seq_K562_Human | 1.27312364 |
| 85 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.26328585 |
| 86 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.25989812 |
| 87 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.23484174 |
| 88 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.22650566 |
| 89 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.20469445 |
| 90 | TP53_16413492_ChIP-PET_HCT116_Human | 1.19498032 |
| 91 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.19112957 |
| 92 | * SOX9_26525672_Chip-Seq_HEART_Mouse | 1.18617935 |
| 93 | * AR_19668381_ChIP-Seq_PC3_Human | 1.16905987 |
| 94 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.15671926 |
| 95 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.14106298 |
| 96 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.12498528 |
| 97 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.12203426 |
| 98 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.11633459 |
| 99 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11493061 |
| 100 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.10918146 |
| 101 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10406318 |
| 102 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.10360952 |
| 103 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.09737403 |
| 104 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.09159369 |
| 105 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.09159369 |
| 106 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.07953016 |
| 107 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07881595 |
| 108 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.07458721 |
| 109 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.07394639 |
| 110 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.06111712 |
| 111 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.04714638 |
| 112 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04636267 |
| 113 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.03588675 |
| 114 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.03022565 |
| 115 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.02942100 |
| 116 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.02888093 |
| 117 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.02868706 |
| 118 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.02502712 |
| 119 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.02041823 |
| 120 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.01240209 |
| 121 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.01131794 |
| 122 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.01036761 |
| 123 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.00772742 |
| 124 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.00674948 |
| 125 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.99890124 |
| 126 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.99164372 |
| 127 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98873367 |
| 128 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.98607855 |
| 129 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.98604843 |
| 130 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.98549387 |
| 131 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.98084263 |
| 132 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.98030242 |
| 133 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.97821592 |
| 134 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.97587087 |
| 135 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97558897 |
| 136 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95777609 |
| 137 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.93850056 |
| 138 | KDM2B_26808549_Chip-Seq_REH_Human | 0.93357292 |
| 139 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.92837907 |
| 140 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92827267 |
| 141 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.92591311 |
| 142 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.92070116 |
| 143 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.89867751 |
| 144 | * JUN_21703547_ChIP-Seq_K562_Human | 0.88137658 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005083_abnormal_biliary_tract | 4.72190998 |
| 2 | MP0002009_preneoplasia | 4.11232820 |
| 3 | MP0008057_abnormal_DNA_replication | 3.57303327 |
| 4 | MP0004145_abnormal_muscle_electrophysio | 3.44858045 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 3.24693760 |
| 6 | MP0003880_abnormal_central_pattern | 3.18327205 |
| 7 | MP0003646_muscle_fatigue | 3.10950578 |
| 8 | MP0000751_myopathy | 3.09980966 |
| 9 | MP0000749_muscle_degeneration | 3.07210970 |
| 10 | MP0002837_dystrophic_cardiac_calcinosis | 2.87384001 |
| 11 | MP0003787_abnormal_imprinting | 2.66908070 |
| 12 | MP0001188_hyperpigmentation | 2.56870445 |
| 13 | MP0003635_abnormal_synaptic_transmissio | 2.51743371 |
| 14 | MP0000003_abnormal_adipose_tissue | 2.25268602 |
| 15 | MP0004270_analgesia | 2.22071920 |
| 16 | MP0003950_abnormal_plasma_membrane | 2.08666245 |
| 17 | MP0009046_muscle_twitch | 2.06621483 |
| 18 | MP0003122_maternal_imprinting | 2.05080339 |
| 19 | MP0009745_abnormal_behavioral_response | 2.03794602 |
| 20 | MP0000733_abnormal_muscle_development | 2.02830046 |
| 21 | MP0006138_congestive_heart_failure | 2.01658857 |
| 22 | MP0002332_abnormal_exercise_endurance | 1.99145800 |
| 23 | MP0001968_abnormal_touch/_nociception | 1.99061927 |
| 24 | MP0001661_extended_life_span | 1.98897963 |
| 25 | MP0002063_abnormal_learning/memory/cond | 1.97386614 |
| 26 | MP0005645_abnormal_hypothalamus_physiol | 1.90927449 |
| 27 | MP0004215_abnormal_myocardial_fiber | 1.87999709 |
| 28 | MP0002736_abnormal_nociception_after | 1.86124311 |
| 29 | MP0002106_abnormal_muscle_physiology | 1.85568833 |
| 30 | MP0002166_altered_tumor_susceptibility | 1.85447993 |
| 31 | MP0002064_seizures | 1.76353825 |
| 32 | MP0004147_increased_porphyrin_level | 1.75369987 |
| 33 | MP0004036_abnormal_muscle_relaxation | 1.67243001 |
| 34 | MP0002572_abnormal_emotion/affect_behav | 1.62925028 |
| 35 | MP0002735_abnormal_chemical_nociception | 1.62242061 |
| 36 | MP0005369_muscle_phenotype | 1.61374575 |
| 37 | MP0004084_abnormal_cardiac_muscle | 1.60915545 |
| 38 | MP0002734_abnormal_mechanical_nocicepti | 1.58208291 |
| 39 | MP0002067_abnormal_sensory_capabilities | 1.57333976 |
| 40 | MP0002396_abnormal_hematopoietic_system | 1.57162628 |
| 41 | MP0005620_abnormal_muscle_contractility | 1.56859013 |
| 42 | MP0000569_abnormal_digit_pigmentation | 1.56761046 |
| 43 | MP0001529_abnormal_vocalization | 1.55275626 |
| 44 | MP0000759_abnormal_skeletal_muscle | 1.55008855 |
| 45 | MP0002184_abnormal_innervation | 1.54530951 |
| 46 | MP0008569_lethality_at_weaning | 1.54463243 |
| 47 | MP0005646_abnormal_pituitary_gland | 1.52015159 |
| 48 | MP0003121_genomic_imprinting | 1.51759469 |
| 49 | MP0010352_gastrointestinal_tract_polyps | 1.50966695 |
| 50 | MP0005423_abnormal_somatic_nervous | 1.50947305 |
| 51 | MP0003763_abnormal_thymus_physiology | 1.49751205 |
| 52 | MP0002272_abnormal_nervous_system | 1.41530981 |
| 53 | MP0001486_abnormal_startle_reflex | 1.39969685 |
| 54 | MP0000383_abnormal_hair_follicle | 1.37692642 |
| 55 | MP0004087_abnormal_muscle_fiber | 1.37537189 |
| 56 | MP0004924_abnormal_behavior | 1.35423228 |
| 57 | MP0005386_behavior/neurological_phenoty | 1.35423228 |
| 58 | MP0004130_abnormal_muscle_cell | 1.34922488 |
| 59 | MP0010630_abnormal_cardiac_muscle | 1.30091318 |
| 60 | MP0004484_altered_response_of | 1.27868704 |
| 61 | MP0001984_abnormal_olfaction | 1.25998240 |
| 62 | MP0002269_muscular_atrophy | 1.25927225 |
| 63 | MP0005248_abnormal_Harderian_gland | 1.21548912 |
| 64 | MP0000778_abnormal_nervous_system | 1.19678321 |
| 65 | MP0002557_abnormal_social/conspecific_i | 1.18651826 |
| 66 | MP0004510_myositis | 1.18370927 |
| 67 | MP0004233_abnormal_muscle_weight | 1.17976755 |
| 68 | MP0005076_abnormal_cell_differentiation | 1.16932956 |
| 69 | MP0003137_abnormal_impulse_conducting | 1.15863693 |
| 70 | MP0001501_abnormal_sleep_pattern | 1.15706035 |
| 71 | MP0002108_abnormal_muscle_morphology | 1.14711477 |
| 72 | MP0010678_abnormal_skin_adnexa | 1.14382898 |
| 73 | MP0005375_adipose_tissue_phenotype | 1.14181851 |
| 74 | MP0001502_abnormal_circadian_rhythm | 1.12905799 |
| 75 | MP0000747_muscle_weakness | 1.12407810 |
| 76 | MP0006276_abnormal_autonomic_nervous | 1.11374830 |
| 77 | MP0000015_abnormal_ear_pigmentation | 1.10246162 |
| 78 | MP0002822_catalepsy | 1.09796738 |
| 79 | MP0005171_absent_coat_pigmentation | 1.09394375 |
| 80 | MP0004811_abnormal_neuron_physiology | 1.08261340 |
| 81 | MP0000372_irregular_coat_pigmentation | 1.08134298 |
| 82 | MP0005220_abnormal_exocrine_pancreas | 1.06237565 |
| 83 | MP0004142_abnormal_muscle_tone | 1.05627444 |
| 84 | MP0002006_tumorigenesis | 1.05258360 |
| 85 | MP0002127_abnormal_cardiovascular_syste | 1.04142010 |
| 86 | MP0005085_abnormal_gallbladder_physiolo | 1.03321276 |
| 87 | MP0005266_abnormal_metabolism | 1.01915494 |
| 88 | MP0003091_abnormal_cell_migration | 0.98491590 |
| 89 | MP0004808_abnormal_hematopoietic_stem | 0.97256472 |
| 90 | MP0008775_abnormal_heart_ventricle | 0.96008884 |
| 91 | MP0001970_abnormal_pain_threshold | 0.94609942 |
| 92 | MP0004085_abnormal_heartbeat | 0.94567489 |
| 93 | * MP0002972_abnormal_cardiac_muscle | 0.94158272 |
| 94 | MP0005330_cardiomyopathy | 0.93570318 |
| 95 | MP0004742_abnormal_vestibular_system | 0.91294921 |
| 96 | MP0000013_abnormal_adipose_tissue | 0.90689471 |
| 97 | MP0001879_abnormal_lymphatic_vessel | 0.88957366 |
| 98 | MP0000955_abnormal_spinal_cord | 0.88691482 |
| 99 | MP0008961_abnormal_basal_metabolism | 0.87186006 |
| 100 | MP0005174_abnormal_tail_pigmentation | 0.86988840 |
| 101 | MP0002877_abnormal_melanocyte_morpholog | 0.86314441 |
| 102 | MP0002971_abnormal_brown_adipose | 0.85827448 |
| 103 | MP0005671_abnormal_response_to | 0.85054391 |
| 104 | MP0003172_abnormal_lysosome_physiology | 0.83708392 |
| 105 | MP0009703_decreased_birth_body | 0.83694739 |
| 106 | MP0003045_fibrosis | 0.83561601 |
| 107 | MP0002066_abnormal_motor_capabilities/c | 0.83534172 |
| 108 | MP0009780_abnormal_chondrocyte_physiolo | 0.80281356 |
| 109 | MP0001873_stomach_inflammation | 0.80248840 |
| 110 | MP0002733_abnormal_thermal_nociception | 0.79208401 |
| 111 | MP0002638_abnormal_pupillary_reflex | 0.78497783 |
| 112 | MP0002095_abnormal_skin_pigmentation | 0.77855284 |
| 113 | MP0003828_pulmonary_edema | 0.73038191 |
| 114 | MP0003183_abnormal_peptide_metabolism | 0.72614799 |
| 115 | MP0000750_abnormal_muscle_regeneration | 0.72510481 |
| 116 | MP0005253_abnormal_eye_physiology | 0.72250329 |
| 117 | MP0004134_abnormal_chest_morphology | 0.72216012 |
| 118 | MP0000230_abnormal_systemic_arterial | 0.71916093 |
| 119 | MP0002089_abnormal_postnatal_growth/wei | 0.71418541 |
| 120 | MP0002163_abnormal_gland_morphology | 0.67386205 |
| 121 | MP0000703_abnormal_thymus_morphology | 0.66986485 |
| 122 | MP0002882_abnormal_neuron_morphology | 0.66944574 |
| 123 | MP0003724_increased_susceptibility_to | 0.66083295 |
| 124 | MP0000266_abnormal_heart_morphology | 0.65787817 |
| 125 | MP0003879_abnormal_hair_cell | 0.65573308 |
| 126 | MP0001544_abnormal_cardiovascular_syste | 0.65568760 |
| 127 | MP0005385_cardiovascular_system_phenoty | 0.65568760 |
| 128 | MP0001348_abnormal_lacrimal_gland | 0.65345466 |
| 129 | MP0000427_abnormal_hair_cycle | 0.65313310 |
| 130 | MP0003959_abnormal_lean_body | 0.64821980 |
| 131 | MP0002168_other_aberrant_phenotype | 0.64781310 |
| 132 | MP0005075_abnormal_melanosome_morpholog | 0.63828047 |
| 133 | MP0003221_abnormal_cardiomyocyte_apopto | 0.62322466 |
| 134 | MP0001943_abnormal_respiration | 0.61733899 |
| 135 | MP0005409_darkened_coat_color | 0.60779741 |
| 136 | MP0000465_gastrointestinal_hemorrhage | 0.60348181 |
| 137 | MP0001851_eye_inflammation | 0.59434878 |
| 138 | MP0003633_abnormal_nervous_system | 0.58867357 |
| 139 | MP0002088_abnormal_embryonic_growth/wei | 0.56658563 |
| 140 | MP0009115_abnormal_fat_cell | 0.56656446 |
| 141 | MP0001784_abnormal_fluid_regulation | 0.56324787 |
| 142 | MP0002128_abnormal_blood_circulation | 0.56207342 |
| 143 | MP0010234_abnormal_vibrissa_follicle | 0.55981829 |
| 144 | MP0003656_abnormal_erythrocyte_physiolo | 0.54931645 |
| 145 | MP0008770_decreased_survivor_rate | 0.54886279 |
| 146 | MP0004043_abnormal_pH_regulation | 0.53520464 |
| 147 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.52875243 |
| 148 | MP0003984_embryonic_growth_retardation | 0.51051929 |
| 149 | MP0005167_abnormal_blood-brain_barrier | 0.49767053 |
| 150 | MP0005535_abnormal_body_temperature | 0.46584129 |
| 151 | MP0005334_abnormal_fat_pad | 0.46322124 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 5.02757515 |
| 2 | Focal motor seizures (HP:0011153) | 4.77461436 |
| 3 | Muscle fiber inclusion bodies (HP:0100299) | 4.66085422 |
| 4 | Febrile seizures (HP:0002373) | 4.59551545 |
| 5 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.49196442 |
| 6 | Nemaline bodies (HP:0003798) | 3.98948801 |
| 7 | Epileptic encephalopathy (HP:0200134) | 3.89700316 |
| 8 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.75829239 |
| 9 | Fetal akinesia sequence (HP:0001989) | 3.61511276 |
| 10 | Exercise-induced muscle cramps (HP:0003710) | 3.60059445 |
| 11 | Cerebellar dysplasia (HP:0007033) | 3.57709112 |
| 12 | Calf muscle hypertrophy (HP:0008981) | 3.55037317 |
| 13 | Abnormality of the nasal septum (HP:0000419) | 3.54353780 |
| 14 | Abnormality of the ischium (HP:0003174) | 3.46488127 |
| 15 | Atonic seizures (HP:0010819) | 3.30928668 |
| 16 | Abnormal hair whorl (HP:0010721) | 3.26568952 |
| 17 | Hyporeflexia of lower limbs (HP:0002600) | 3.21148148 |
| 18 | Abnormality of the calf musculature (HP:0001430) | 3.19460009 |
| 19 | Broad-based gait (HP:0002136) | 3.18087928 |
| 20 | Type 1 muscle fiber predominance (HP:0003803) | 3.17114721 |
| 21 | Frequent falls (HP:0002359) | 3.14252075 |
| 22 | Calcaneovalgus deformity (HP:0001848) | 3.10235589 |
| 23 | Protruding tongue (HP:0010808) | 3.02978453 |
| 24 | Subaortic stenosis (HP:0001682) | 2.96266596 |
| 25 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.96266596 |
| 26 | Distal arthrogryposis (HP:0005684) | 2.94745784 |
| 27 | Myopathic facies (HP:0002058) | 2.91860573 |
| 28 | Focal seizures (HP:0007359) | 2.89271912 |
| 29 | Hyperventilation (HP:0002883) | 2.84583864 |
| 30 | Submucous cleft hard palate (HP:0000176) | 2.75786837 |
| 31 | Abnormal finger flexion creases (HP:0006143) | 2.74340001 |
| 32 | EMG: myopathic abnormalities (HP:0003458) | 2.72076071 |
| 33 | Deformed tarsal bones (HP:0008119) | 2.68730139 |
| 34 | Absence seizures (HP:0002121) | 2.67972538 |
| 35 | Short chin (HP:0000331) | 2.66089213 |
| 36 | Long clavicles (HP:0000890) | 2.64067984 |
| 37 | Subacute progressive viral hepatitis (HP:0006572) | 2.58902361 |
| 38 | Hyperkalemia (HP:0002153) | 2.55530702 |
| 39 | Increased circulating renin level (HP:0000848) | 2.53130289 |
| 40 | Weak cry (HP:0001612) | 2.52929522 |
| 41 | Poor eye contact (HP:0000817) | 2.52538426 |
| 42 | Myotonia (HP:0002486) | 2.51856873 |
| 43 | Abnormality of alanine metabolism (HP:0010916) | 2.48634323 |
| 44 | Hyperalaninemia (HP:0003348) | 2.48634323 |
| 45 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.48634323 |
| 46 | Gaze-evoked nystagmus (HP:0000640) | 2.41906953 |
| 47 | Bundle branch block (HP:0011710) | 2.41814878 |
| 48 | Progressive cerebellar ataxia (HP:0002073) | 2.39175903 |
| 49 | Abnormality of B cell number (HP:0010975) | 2.37955925 |
| 50 | B lymphocytopenia (HP:0010976) | 2.37955925 |
| 51 | Abnormality of the calcaneus (HP:0008364) | 2.36402556 |
| 52 | Ulnar deviation of the wrist (HP:0003049) | 2.34346235 |
| 53 | Generalized muscle weakness (HP:0003324) | 2.33357689 |
| 54 | Oligomenorrhea (HP:0000876) | 2.31197827 |
| 55 | Lower limb amyotrophy (HP:0007210) | 2.29799596 |
| 56 | Type 2 muscle fiber atrophy (HP:0003554) | 2.28974023 |
| 57 | Nonprogressive disorder (HP:0003680) | 2.28248413 |
| 58 | Visual hallucinations (HP:0002367) | 2.27011315 |
| 59 | Papillary thyroid carcinoma (HP:0002895) | 2.26893168 |
| 60 | Alkalosis (HP:0001948) | 2.26631263 |
| 61 | Distal lower limb amyotrophy (HP:0008944) | 2.25760588 |
| 62 | Shoulder girdle muscle weakness (HP:0003547) | 2.24232871 |
| 63 | Bicuspid aortic valve (HP:0001647) | 2.23877840 |
| 64 | Round ear (HP:0100830) | 2.23380678 |
| 65 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.22093644 |
| 66 | Hypokalemic alkalosis (HP:0001949) | 2.21353119 |
| 67 | Difficulty running (HP:0009046) | 2.21213212 |
| 68 | Scanning speech (HP:0002168) | 2.18680716 |
| 69 | Dysmetric saccades (HP:0000641) | 2.14571048 |
| 70 | Broad face (HP:0000283) | 2.13022850 |
| 71 | Dislocated radial head (HP:0003083) | 2.11879102 |
| 72 | Neoplasm of the heart (HP:0100544) | 2.11860181 |
| 73 | Abnormality of the radial head (HP:0003995) | 2.10921760 |
| 74 | Myoglobinuria (HP:0002913) | 2.10554028 |
| 75 | Truncal obesity (HP:0001956) | 2.09385831 |
| 76 | Ulnar deviation of finger (HP:0009465) | 2.08674716 |
| 77 | Abnormality of the neuromuscular junction (HP:0003398) | 2.05913449 |
| 78 | Fatigable weakness (HP:0003473) | 2.05913449 |
| 79 | Thickened helices (HP:0000391) | 2.05684571 |
| 80 | Dialeptic seizures (HP:0011146) | 2.04463100 |
| 81 | EMG: neuropathic changes (HP:0003445) | 2.00740365 |
| 82 | Sudden death (HP:0001699) | 2.00388282 |
| 83 | Pelvic girdle muscle weakness (HP:0003749) | 2.00311971 |
| 84 | Heterotopia (HP:0002282) | 2.00064079 |
| 85 | Absent speech (HP:0001344) | 1.99936019 |
| 86 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.99918264 |
| 87 | Menstrual irregularities (HP:0000858) | 1.99885342 |
| 88 | Prolonged QT interval (HP:0001657) | 1.99856163 |
| 89 | Supraventricular tachycardia (HP:0004755) | 1.99791305 |
| 90 | Malignant hyperthermia (HP:0002047) | 1.99347000 |
| 91 | Increased variability in muscle fiber diameter (HP:0003557) | 1.98933197 |
| 92 | Abnormal social behavior (HP:0012433) | 1.98905094 |
| 93 | Impaired social interactions (HP:0000735) | 1.98905094 |
| 94 | Primary atrial arrhythmia (HP:0001692) | 1.97884600 |
| 95 | * Blue irides (HP:0000635) | 1.96649672 |
| 96 | Abnormal EKG (HP:0003115) | 1.95725006 |
| 97 | Muscular dystrophy (HP:0003560) | 1.95390786 |
| 98 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.95218084 |
| 99 | Cystic hygroma (HP:0000476) | 1.94544422 |
| 100 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.93564461 |
| 101 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.93564461 |
| 102 | Bulbar palsy (HP:0001283) | 1.92646061 |
| 103 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.92128857 |
| 104 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.91966237 |
| 105 | Polyphagia (HP:0002591) | 1.90785967 |
| 106 | Supraventricular arrhythmia (HP:0005115) | 1.90574048 |
| 107 | Muscle stiffness (HP:0003552) | 1.90474084 |
| 108 | Hypoplasia of the iris (HP:0007676) | 1.90433614 |
| 109 | Widely spaced teeth (HP:0000687) | 1.90431348 |
| 110 | Atrial fibrillation (HP:0005110) | 1.90072843 |
| 111 | Hypoplastic ischia (HP:0003175) | 1.89928006 |
| 112 | Hypoventilation (HP:0002791) | 1.89487713 |
| 113 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.88694801 |
| 114 | Abnormality of the labia minora (HP:0012880) | 1.88269435 |
| 115 | Prominent nose (HP:0000448) | 1.88089498 |
| 116 | Generalized tonic-clonic seizures (HP:0002069) | 1.87832230 |
| 117 | Narrow nasal bridge (HP:0000446) | 1.87248968 |
| 118 | Drooling (HP:0002307) | 1.86741927 |
| 119 | Excessive salivation (HP:0003781) | 1.86741927 |
| 120 | Aortic aneurysm (HP:0004942) | 1.85573165 |
| 121 | Muscle fiber splitting (HP:0003555) | 1.84523560 |
| 122 | Abnormal auditory evoked potentials (HP:0006958) | 1.83970277 |
| 123 | Lipoatrophy (HP:0100578) | 1.83628177 |
| 124 | Neuroendocrine neoplasm (HP:0100634) | 1.82765843 |
| 125 | Muscle fiber atrophy (HP:0100295) | 1.82595860 |
| 126 | Knee flexion contracture (HP:0006380) | 1.80758089 |
| 127 | Increased connective tissue (HP:0009025) | 1.80611407 |
| 128 | Truncal ataxia (HP:0002078) | 1.78449238 |
| 129 | * Fair hair (HP:0002286) | 1.78096876 |
| 130 | Tented upper lip vermilion (HP:0010804) | 1.76448810 |
| 131 | Abnormality of the epiphyses of the hand (HP:0005924) | 1.76110681 |
| 132 | Genetic anticipation (HP:0003743) | 1.75528787 |
| 133 | Rimmed vacuoles (HP:0003805) | 1.74210158 |
| 134 | Heterochromia iridis (HP:0001100) | 1.72962933 |
| 135 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.72907972 |
| 136 | Fatigue (HP:0012378) | 1.72597618 |
| 137 | Hypoplastic nipples (HP:0002557) | 1.72321991 |
| 138 | Neck muscle weakness (HP:0000467) | 1.71284377 |
| 139 | Volvulus (HP:0002580) | 1.69439943 |
| 140 | Rhabdomyolysis (HP:0003201) | 1.69289231 |
| 141 | Left ventricular hypertrophy (HP:0001712) | 1.68724761 |
| 142 | Absent phalangeal crease (HP:0006109) | 1.68321437 |
| 143 | Steppage gait (HP:0003376) | 1.68055083 |
| 144 | Hypoplasia of the pons (HP:0012110) | 1.67150363 |
| 145 | Urinary urgency (HP:0000012) | 1.67080699 |
| 146 | Thyroiditis (HP:0100646) | 1.66754215 |
| 147 | Abnormality involving the epiphyses of the upper limbs (HP:0003839) | 1.65559687 |
| 148 | Hypothermia (HP:0002045) | 1.64866439 |
| 149 | Abnormal eating behavior (HP:0100738) | 1.63621257 |
| 150 | Cubitus valgus (HP:0002967) | 1.63113939 |
| 151 | Osteolytic defects of the hand bones (HP:0009699) | 1.62882506 |
| 152 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.62882506 |
| 153 | Failure to thrive in infancy (HP:0001531) | 1.62768594 |
| 154 | Abnormality of potassium homeostasis (HP:0011042) | 1.62350442 |
| 155 | Dilated cardiomyopathy (HP:0001644) | 1.62260088 |
| 156 | Growth hormone deficiency (HP:0000824) | 1.61532913 |
| 157 | Areflexia of lower limbs (HP:0002522) | 1.59790559 |
| 158 | Stereotypic behavior (HP:0000733) | 1.57729655 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.82193561 |
| 2 | SIK3 | 4.67412233 |
| 3 | STK39 | 3.53554846 |
| 4 | MAP2K7 | 3.49937903 |
| 5 | MAP3K12 | 3.30147050 |
| 6 | FRK | 3.23167296 |
| 7 | OBSCN | 3.11124401 |
| 8 | MAP3K4 | 2.96277508 |
| 9 | NTRK2 | 2.53439892 |
| 10 | WNK4 | 2.50001996 |
| 11 | MARK1 | 2.35368092 |
| 12 | OXSR1 | 2.24096300 |
| 13 | NTRK3 | 2.23015147 |
| 14 | TXK | 2.16692609 |
| 15 | LATS1 | 2.13921568 |
| 16 | PHKG2 | 2.10621890 |
| 17 | PHKG1 | 2.10621890 |
| 18 | CDK19 | 1.92386703 |
| 19 | BRD4 | 1.89725605 |
| 20 | DAPK1 | 1.89379123 |
| 21 | MAPK13 | 1.81976848 |
| 22 | KSR1 | 1.73489264 |
| 23 | TNIK | 1.64235756 |
| 24 | PRPF4B | 1.58374369 |
| 25 | MST1R | 1.58165778 |
| 26 | NEK6 | 1.57204546 |
| 27 | MUSK | 1.56566463 |
| 28 | EIF2AK3 | 1.51891062 |
| 29 | TSSK6 | 1.49811000 |
| 30 | SGK2 | 1.48755825 |
| 31 | MAP2K4 | 1.44324837 |
| 32 | ACVR1B | 1.27504795 |
| 33 | MINK1 | 1.25799784 |
| 34 | NLK | 1.24655991 |
| 35 | TTN | 1.22953030 |
| 36 | EEF2K | 1.21457063 |
| 37 | MAP3K7 | 1.20621835 |
| 38 | DAPK2 | 1.19787060 |
| 39 | ERBB3 | 1.19618040 |
| 40 | BMPR1B | 1.19046652 |
| 41 | AKT3 | 1.18123001 |
| 42 | PINK1 | 1.11378132 |
| 43 | STK38L | 1.10520110 |
| 44 | CCNB1 | 1.10360526 |
| 45 | STK24 | 1.09963274 |
| 46 | PLK2 | 1.08149014 |
| 47 | CAMKK2 | 1.07708336 |
| 48 | NME1 | 1.05164212 |
| 49 | MAPK11 | 1.00038668 |
| 50 | DMPK | 0.96201490 |
| 51 | CDK12 | 0.96164532 |
| 52 | FGFR3 | 0.92259291 |
| 53 | PDK3 | 0.92212956 |
| 54 | PDK4 | 0.92212956 |
| 55 | SGK3 | 0.91602152 |
| 56 | LATS2 | 0.88999717 |
| 57 | CDK8 | 0.88122267 |
| 58 | NEK1 | 0.85244638 |
| 59 | EPHA4 | 0.84887741 |
| 60 | VRK1 | 0.84220255 |
| 61 | PRKAA2 | 0.82749634 |
| 62 | CDK3 | 0.80120844 |
| 63 | MAPKAPK3 | 0.78454587 |
| 64 | CAMK1 | 0.78001250 |
| 65 | ZAK | 0.77613784 |
| 66 | MAPK12 | 0.74663476 |
| 67 | PDGFRB | 0.73828482 |
| 68 | PIK3CA | 0.73490389 |
| 69 | SIK2 | 0.73064009 |
| 70 | MET | 0.73027314 |
| 71 | CAMK4 | 0.71924056 |
| 72 | MELK | 0.70846259 |
| 73 | TEC | 0.69369371 |
| 74 | MAP3K6 | 0.68068980 |
| 75 | MARK2 | 0.67391962 |
| 76 | RPS6KB2 | 0.67348944 |
| 77 | SGK494 | 0.67246574 |
| 78 | SGK223 | 0.67246574 |
| 79 | TLK1 | 0.66998771 |
| 80 | RPS6KB1 | 0.66101075 |
| 81 | FER | 0.65911214 |
| 82 | BCR | 0.64623772 |
| 83 | EIF2AK2 | 0.64567599 |
| 84 | TGFBR2 | 0.64175138 |
| 85 | TAOK3 | 0.63648595 |
| 86 | TAOK2 | 0.63541635 |
| 87 | BRSK2 | 0.63121213 |
| 88 | CDK5 | 0.63084845 |
| 89 | FES | 0.62387500 |
| 90 | UHMK1 | 0.61653486 |
| 91 | EPHA3 | 0.58264472 |
| 92 | IRAK4 | 0.56663688 |
| 93 | MARK3 | 0.55768579 |
| 94 | SGK1 | 0.54867298 |
| 95 | MTOR | 0.54461974 |
| 96 | NTRK1 | 0.52704180 |
| 97 | MAP4K2 | 0.51169829 |
| 98 | CDK18 | 0.47638801 |
| 99 | CAMK2A | 0.46485334 |
| 100 | MAP3K14 | 0.46344860 |
| 101 | PDK2 | 0.46095014 |
| 102 | TRPM7 | 0.45936632 |
| 103 | PDK1 | 0.45754136 |
| 104 | MAPK10 | 0.45616898 |
| 105 | STK3 | 0.44965118 |
| 106 | PIK3CG | 0.43912568 |
| 107 | PRKCG | 0.43844507 |
| 108 | MAP2K6 | 0.43591578 |
| 109 | ITK | 0.43035141 |
| 110 | CAMK2B | 0.43033207 |
| 111 | ADRBK2 | 0.42698625 |
| 112 | CAMKK1 | 0.42350362 |
| 113 | PRKAA1 | 0.41828094 |
| 114 | ICK | 0.41443453 |
| 115 | GRK5 | 0.40234691 |
| 116 | JAK1 | 0.40012719 |
| 117 | PIM1 | 0.39524282 |
| 118 | RAF1 | 0.38460844 |
| 119 | TNK2 | 0.37969729 |
| 120 | CDK6 | 0.37867121 |
| 121 | TAOK1 | 0.37711042 |
| 122 | MYLK | 0.37620729 |
| 123 | INSRR | 0.37559601 |
| 124 | CAMK1G | 0.37253127 |
| 125 | PRKCH | 0.37180386 |
| 126 | MAPKAPK5 | 0.37020678 |
| 127 | BMPR2 | 0.36636670 |
| 128 | RET | 0.36569369 |
| 129 | MKNK2 | 0.36564940 |
| 130 | WNK1 | 0.36313378 |
| 131 | CAMK1D | 0.35528825 |
| 132 | SYK | 0.35446622 |
| 133 | MAP4K1 | 0.34758268 |
| 134 | STK38 | 0.33453721 |
| 135 | MAPK7 | 0.33352743 |
| 136 | RPS6KA3 | 0.32907578 |
| 137 | STK11 | 0.32760111 |
| 138 | MAPK4 | 0.32239978 |
| 139 | GSK3A | 0.32192253 |
| 140 | PRKCE | 0.32086037 |
| 141 | CAMK2D | 0.32006217 |
| 142 | LCK | 0.30537669 |
| 143 | IRAK2 | 0.30504367 |
| 144 | CHUK | 0.29894952 |
| 145 | FGFR2 | 0.29602109 |
| 146 | RPS6KA5 | 0.29589100 |
| 147 | MAPK8 | 0.28450419 |
| 148 | MAP2K1 | 0.27932239 |
| 149 | TIE1 | 0.27357911 |
| 150 | TGFBR1 | 0.26910376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.90676888 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.78790939 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.29239262 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.26929231 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.12667891 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.09932089 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.99592168 |
| 8 | * Morphine addiction_Homo sapiens_hsa05032 | 1.95768569 |
| 9 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.72660156 |
| 10 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.72496184 |
| 11 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.66025733 |
| 12 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.60543391 |
| 13 | GABAergic synapse_Homo sapiens_hsa04727 | 1.58324989 |
| 14 | ABC transporters_Homo sapiens_hsa02010 | 1.47860080 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.46782599 |
| 16 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.45918323 |
| 17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.44889265 |
| 18 | Insulin secretion_Homo sapiens_hsa04911 | 1.44615718 |
| 19 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.44511656 |
| 20 | Long-term potentiation_Homo sapiens_hsa04720 | 1.43774894 |
| 21 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.42896590 |
| 22 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.42482178 |
| 23 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.39940356 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.34415790 |
| 25 | Taste transduction_Homo sapiens_hsa04742 | 1.33543256 |
| 26 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.31737822 |
| 27 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.31198360 |
| 28 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.31044496 |
| 29 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.29069467 |
| 30 | Salivary secretion_Homo sapiens_hsa04970 | 1.27323015 |
| 31 | Circadian rhythm_Homo sapiens_hsa04710 | 1.27275418 |
| 32 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.21166595 |
| 33 | Long-term depression_Homo sapiens_hsa04730 | 1.20430830 |
| 34 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.18778203 |
| 35 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.18495926 |
| 36 | Viral myocarditis_Homo sapiens_hsa05416 | 1.16698062 |
| 37 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.13295367 |
| 38 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.12969501 |
| 39 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.12311528 |
| 40 | Focal adhesion_Homo sapiens_hsa04510 | 1.10037968 |
| 41 | Adherens junction_Homo sapiens_hsa04520 | 1.09634273 |
| 42 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.09252756 |
| 43 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.08694344 |
| 44 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.07707934 |
| 45 | MAPK signaling pathway_Homo sapiens_hsa04010 | 1.06840434 |
| 46 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.05638317 |
| 47 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.05111860 |
| 48 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.04953849 |
| 49 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.04037638 |
| 50 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.04020331 |
| 51 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.03465912 |
| 52 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.01766250 |
| 53 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.99435907 |
| 54 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.99062729 |
| 55 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.98674561 |
| 56 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.98527689 |
| 57 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.98447322 |
| 58 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.97986756 |
| 59 | Alcoholism_Homo sapiens_hsa05034 | 0.97888725 |
| 60 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.97631545 |
| 61 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.97228744 |
| 62 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.95958363 |
| 63 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.93331544 |
| 64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.91354238 |
| 65 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.89498983 |
| 66 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 0.88518157 |
| 67 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.87952279 |
| 68 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.86481565 |
| 69 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.85599582 |
| 70 | Cocaine addiction_Homo sapiens_hsa05030 | 0.85366859 |
| 71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.83586475 |
| 72 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.82246547 |
| 73 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.82179937 |
| 74 | Colorectal cancer_Homo sapiens_hsa05210 | 0.81622901 |
| 75 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.80504389 |
| 76 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.80248022 |
| 77 | Axon guidance_Homo sapiens_hsa04360 | 0.80204662 |
| 78 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.79345696 |
| 79 | Gap junction_Homo sapiens_hsa04540 | 0.78365467 |
| 80 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.78110019 |
| 81 | Glioma_Homo sapiens_hsa05214 | 0.76861092 |
| 82 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.75232195 |
| 83 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.74614025 |
| 84 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.74184148 |
| 85 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.73194254 |
| 86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.73083609 |
| 87 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.71272528 |
| 88 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.70375676 |
| 89 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.69330835 |
| 90 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.68320787 |
| 91 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.67821627 |
| 92 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.67222908 |
| 93 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.66312460 |
| 94 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.65159422 |
| 95 | Amoebiasis_Homo sapiens_hsa05146 | 0.64785608 |
| 96 | Prostate cancer_Homo sapiens_hsa05215 | 0.64746360 |
| 97 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63891356 |
| 98 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.60741055 |
| 99 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.60131927 |
| 100 | Lysine degradation_Homo sapiens_hsa00310 | 0.59604155 |
| 101 | Pathways in cancer_Homo sapiens_hsa05200 | 0.59239038 |
| 102 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.58587223 |
| 103 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.58116750 |
| 104 | Platelet activation_Homo sapiens_hsa04611 | 0.57902440 |
| 105 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.57759971 |
| 106 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56738300 |
| 107 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.56484360 |
| 108 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56032967 |
| 109 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.55674329 |
| 110 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55578831 |
| 111 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.55547757 |
| 112 | Measles_Homo sapiens_hsa05162 | 0.55508486 |
| 113 | Allograft rejection_Homo sapiens_hsa05330 | 0.55482440 |
| 114 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.55105931 |
| 115 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.55030358 |
| 116 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.54664656 |
| 117 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.53872586 |
| 118 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.53475052 |
| 119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51069680 |
| 120 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.51007571 |
| 121 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.50462170 |
| 122 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.50009720 |
| 123 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.49677171 |
| 124 | Melanogenesis_Homo sapiens_hsa04916 | 0.49401615 |
| 125 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.48636459 |
| 126 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.48544964 |
| 127 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.48207095 |
| 128 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.47918779 |
| 129 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.46989330 |
| 130 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.46691831 |
| 131 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.46419719 |
| 132 | Hepatitis B_Homo sapiens_hsa05161 | 0.45843331 |
| 133 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.45576632 |
| 134 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.44585429 |
| 135 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.44239221 |
| 136 | Phagosome_Homo sapiens_hsa04145 | 0.43983554 |
| 137 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43735018 |
| 138 | Insulin resistance_Homo sapiens_hsa04931 | 0.43608199 |
| 139 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43535290 |

